Summary. -Grass carp reovirus (GCRV) of the genus Aquareovirus and the family Reoviridae causes a severe hemorrhagic disease in grass carp fingerlings in China. GCRV genome is composed of 11 double-stranded RnA segments, of which segment 8 encodes the major core capsid protein VP6. In this study, the VP6 gene following an RT-PCR-amplification from the GCRV 104 strain was cloned into an expression vector pET-32a to obtain pET-32(a)-VP6. The VP6 protein was expressed in Escherichia coli bL21 as a fusion protein of 64 kda. After purification with the HisLink Spin Protein Purification System the VP6 protein was used to raise a specific polyclonal antibody in balb/c mice. Presence of VP6 protein was proved in bacterial lysates containing VP6 fusion protein by Western blot analysis and in GCRV-infected CIK cells by immunofluorescent staining using polyclonal antibody. These results may be helpful in further studies of interactions between GCRV and cells and in preparation of an engineered vaccine against GCRV.
Introduction
Grass carp hemorrhage caused by GCRV (Cheng et al., 2008 ) is a highly infectious, fatal viral disease affecting grass carp fingerlings in China. GCRV is a member of the genus Aquareovirus of the family Reoviridae, which belongs to the species Aquareovirus C (Fang et al., 2005; Lupiani et al., 1993; Regenmortel et al., 2000; Attoui et al., 2002) . The genome of GCRV is composed of 11 double-stranded RnA segments.
It has been reported that the GCRV could be detected by staphylococcus protein A coagglutination (Yang et al., 1991) , ELISA, fluorescent antibody technique (Li et al., 1999) , dot-ELISA (Shao et al., 1996) and RT-PCR (Wang et al., 1997) . Since GCRV VP6 protein has high immunogenicity, it will be suitable for raising the polyclonal antibody (Wang et al., 1995) . In this study, we amplified, cloned and expressed the GCRV VP6 gene in E. coli. Using a purified VP6 protein, we raised in balb/c mice a polyclonal antibody which was able to specifically detect the VP6 protein in bacterial lysates by Western blot analysis and in virus-infected cells by immunofluorescence staining. These results contribute to the knowledge of the interaction between GCRV and cells and preparation of an engineered vaccine against GCRV.
Materials and Methods
Virus and cells. The GCRV104 (CCTCC nO: V201217) was originally isolated from the diseased grass carp with hemorrhage symptoms in 2009 in China and was passaged in the CIK cell line. The CIK cells were cultured in MEM supplemented with 10% bovine fetal serum with pH 6.8 at 28°C (Zuo et al., 1983) .
Cloning of VP6 gene. GCRV genomic dsRnA was extracted from the infected CIK cell cultures with Trizol Reagent (Invitrogen, USA) following manufacturer΄s recommendations. A pair of specific primers P1/ P2 for amplifying GCRV VP6 gene was designed by using Primer Premier 5 software based on the sequence information of GCRV VP6 gene and the expression vector pET-32a(+) (novagen, USA). The sequence of P1 is CGGGATCC ATGGCACGTGTGGTTTATG (forward) containing the BamHI and P2 is CCAAGCTT ATGTGGTTACGCGGGTCAG (reverse) containing the HindIII restriction site (restriction sites are underlined). A full length GCRV VP6 gene was produced by RT-PCR amplification, and the amplified fragment was cloned into prokaryotic expression vector pET-32a(+). The recombinant plasmid, which was designated as pET-32(a)-VP6, was then transformed into E. coli bL21(dE3) host cells. The recombinant plasmid was extracted using the Plasmid Miniprep kit (Omega bio-Tek, USA) and analyzed by PCR, restriction enzyme digestion, and sequencing (Shanghai Sangon biological Engineering Technology & Services Co., Ltd).
Expression of his-tagged VP6 protein. The VP6 protein expression was induced by addition of 0.5 or 1 mmol/l IPTG. At 1, 2, 4 or 8 hrs after the addition of IPTG, 1ml of the culture was collected and centrifuged. The bacterial pellet was resuspended in Laemmli sample buffer (bio-rad, USA) and boiled for 5 min before SdS-PAGE analysis.
Preparation of polyclonal VP6 antisera. Recombinant proteins were purified using HisLink Soin Protein Purification System kit (Promega, USA) and analyzed by SdS-PAGE. Concentration of the purified proteins was determined by using the bradford assay. To prepare antisera, 20 μg of the recombinant proteins were used to immunize balb/c mice intraperitoneally with Quick Antibody immunoadjuvant (Kbqbio, beiJing) at day 1 and 21.
Titration of VP6 antisera by ELISA. The 96-well plate (Corning, USA) was coated with recombinant protein at concentration of 5 μg/ ml at 4°C, overnight. Polyclonal VP6 mouse antiserum and unimmunized mouse serum (negative control) were added to the plate separately and were incubated 1 hr at 37°C. The plates were washed with buffer (PbS containing 0.05% Tween 20) and HRP-conjugated rabbit anti-mouse antibody (Kbqbio, beiJing) was added to each well and incubated 1 hr at 37°C. After washing, O-phenyldiamine (OPd) was added to each well and the reaction was stopped with 2 mol/l sulfuric acid. ELISA titers were measured at A490 and expressed as the reciprocal of the last dilution of sera.
Western blot analysis. CIK cells infected with GCRV were collected and total proteins were extracted by boiling and thawing, separated by 12% SdS-PAGE and then transferred to a nitrocellulose membrane by a semi-dry transfer cell (bio Rad, USA) at 15 V for 30 min. The membrane was blocked with 5% bSA in the TbS buffer (50 mmol/l Tris-HCl, 200 mmol/l naCl, pH 7.5) at 37°C for 2 hrs. Subsequently, the membrane was probed with OnE-HOUR Western kit (Genscript, nanJing) following the manufacturer΄s instructions.
Immunofluorescent staining. CIK cell monolayer was infected by GCRV (MOI = 0.5) at 28°C for 24 hrs and fixed with 4% paraformaldehyde. After fixation, cells were incubated with polyclonal VP6-specific antiserum for 1 hr, followed by washing three times with PbS. Goat anti mouse IgG Cy3 (1:50) was added and incubated at 37°C for 45 min. Images were taken with fluorescence microscope (Leica, germany).
Results

Cloning and expression of VP6 gene
The full-length GCRV VP6 gene was composed of 1,319 bp (Acc. no. Jn967636) and an open reading frame (ORF) of 1,257 bp encoding an 418 aa protein VP6. Primer pair P1/P2 was designed to amplify the full length ORF of GCRV VP6 gene. The PCR amplified product was analyzed in 1.2% agarose gel (Fig. 1) and cloned into the vector pMd18-T and confirmed by sequencing. Amplified GCRV VP6 gene was digested with BamHI and HindIII and cloned into expression vector pET-32a(+) digested with the same enzymes to construct the recombinant plasmid pET-32(a)-VP6. The obtained recombinant clones were verified by BamHI and HindIII digestion (Fig. 2) , which generated two bands at 1,257 bp and 5,900 bp, respectively. both restriction enzyme digestion and dnA sequencing were used for plasmid pET-32(a)-VP6 verification (Fig. 3) .
SdS-PAGE analysis showed a band with molecular mass of 64 kda, which was equal to the molecular mass sum of the VP6 protein (46 kda) and the expression vector pET-32a(+) (18 kda) (Fig. 4) . In addition, SdS-PAGE analysis showed that target protein was mainly present in the inclusion bodies.
Optimization of induction
To determine the optimal conditions for VP6 protein expression, two major parameters were examined including the IPTG concentration and incubation duration. The results from different induction times are shown in Fig. 5 . After induction for 1-8 hrs, a steady expression level of VP6 was observed, and the highest production of VP6 was after 8 hrs. There was no significant difference in the different IPTG concentration conditions (0.5 mmol/l or 1 mmol/l).
Characterization of polyclonal VP6 antisera
The recombinant proteins with the 3' terminal fused histagged proteins were purified using HisLink Soin Protein Purification System kit and analyzed by SdS-PAGE (Fig. 6) . The SdS-PAGE result showed the purity of purified fusion protein. The concentration of the fusion protein was 140 μg/ ml as determined by bradford assay.
Serum samples were taken at day 26 post-immunization and analyzed by ELISA and Western blot analysis. Antibody titers (A492) were detected as high as 20,000 (Fig. 7) . The VP6 protein was detected by SdS-PAGE followed by Western blot analysis with the polyclonal antibodies against the VP6 protein. The Western blot analysis demonstrated a protein with a molecular mass of 64 kda (Fig. 8) .
Immunofluorescent staining of virus-infected cells for VP6 protein
The CIK cells infected by GCRV were positive in immunofluorescence already at day 1 post-infection. Increased fluorescence, in comparison to uninfected CIK cells, could be seen also after 3 days (Fig. 9) .
Discussion
The GCRV VP6 protein encoded by the genomic segment 8 is similar to the σ2 protein of MRV and occupies a similar structural position in the virus (Fang et al., 2005) . Early studies have also demonstrated that the σ2 protein of MRV or the VP6 protein is essential for core shell assembly (Leslie et al., 2007; Kim et al., 2002) . In recent years, Hill and Zhou found that some reoviruses in the genus of Cypovirus, are similar to the GCRV core and have nodule proteins at the same positions as those of other aquareoviruses which serve as a stabilizing clamp to enhance VP3 (λ1 analogue) core frame intensity (Hill et al., 1999; Zhou et al., 2003) . Some researchers have investigated immunogenicity of rotavirus VP6. This protein is highly immunogenic but does not induce neutralizing antibodies. Since antibodies against VP6 are highly cross reactive among group A of rotaviruses, VP6 immunization could potentially provide heterotypic protection (Tang et al., 1997) . Vaccine development studies have shown a high level of protection when VP6 was used as an immunogen in experimental models (Choi et al., 2002; dong et al., 2005; Yu and Langridge, 2003) , so VP6 protein is a good target protein for immunological assays (Wang et al., 1995) .
In this study, the recombinant protein VP6 present in inclusion bodies formed a compact particle composed of aggregate proteins due to the hydrophobic interactions and high expression level of recombinant protein. Inclusion bod- 
SDS-PAGE and Western blot analysis of lysate of transformed E. coli
Induction with 1 mmol/l IPTG and harvest after 4 hrs. SdS-PAGE (lanes 1-2), Western blot analysis for VP6 using the antiserum (lanes 3-4) . Induced GCRV VP6 product (lanes 1, 3) , non-induced control (lanes 2, 4). Protein size markers (lane M). ies can prevent protein from degradation and also protect host cells from incorrectly folded recombinant proteins. Compared to antibodies against GCRV, recombinant protein VP6 antibodies could be a better tool for the study of GCRV VP6 (Zhang et al., 2008) .
In conclusion, we expressed the VP6 protein in the host strain E. coli bL21 (dE3). Fusion protein was used to raise specific polyclonal antibodies in balb/c mice. Western blot and immunofluorescence analysis indicated high specificity of VP6 polyclonal antibody. These results provide a solid foundation for further research on aspects of immunity and preparation of immunoreagents.
